Comment on: Achieving inactive disease in enthesitis-related arthritis with secukinumab following TNF-inhibitor failure.
Overview publication
Title | Comment on: Achieving inactive disease in enthesitis-related arthritis with secukinumab following TNF-inhibitor failure. |
Date | 2024-11-01 |
Issue name | Rheumatology (Oxford, England) |
Issue number | v63.11:e319-e320 |
DOI | 10.1093/rheumatology/keae148 |
PubMed | 38460185 |
Authors | |
Read | Read publication |